Key Findings:  These results suggest that the CB2 receptor may represent a new target for modulating the inflammatory reaction induced by mycobacteria.
Type of Study:  Animal Study
Study Result:  Positive
Research Location(s):  Brazil
Year of Pub:  2016
Cannabinoids Studied: 
Terpenes Studied:  ß-Caryophyllene
Receptors Studied:  CB2
Dosage: BCP (0.5-50 mg/kg) or intraperitonealy with GP1a (10 mg/kg) 1 h before the induction of pleurisy or pulmonary inflammation by BCG.
Route of Administration:  Injection, Oral (Ingestion)
Citation:  Andrade-Silva M, et al. The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration. Inflamm Res. 2016; 65:869-879. doi: 10.1007/s00011-016-0969-3
Authors:  Andrade-Silva M, Correa LB, Candéa AL, Cavalher-Machado SC, Barbosa HS, Rosas EC, Henriques MG